SCHEMBL744473

SCHEMBL744473

O=C(O)c1cc(Cl)cc(C(=O)O)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.61
TSHR P16473 2/20 0.61
HIF1A Q16665 1/20 0.61
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ACMSD Q8TDX5 1/20 0.50
TPMT P51580 1/20 0.50
KMO O15229 4/20 0.47
GPR35 Q9HC97 1/20 0.47
MCL1 Q07820 1/20 0.43
HCAR1 Q9BXC0 1/20 0.43
HCAR2 Q8TDS4 1/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28932404 0.97 ALOX15 (0.58) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL19857484 0.89 ALOX15 (0.50) ALOX15TSHRHIF1ATDP1KDM4E
Dipicolinic Acid SCHEMBL11376097 0.89 ALOX15 (0.71) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL365280 0.88 ALOX15 (0.48) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL29462184 0.88 ALOX15 (0.48) ALOX15TSHRHIF1ATDP1KDM4E
Hydrochloric Acid SCHEMBL7233021 0.86 ALOX15 (0.46) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL24742269 0.84 MCL1 (0.45) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL1421869 0.84 ALDH1A1 (0.50) ALOX15TSHRHIF1ATDP1TPMT
SCHEMBL31224613 0.84 ALOX15 (0.45) ALOX15TSHRHIF1ATDP1KDM4E
SCHEMBL7078655 0.84 ALOX15 (0.45) ALOX15TSHRHIF1ATDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118878806-B Zinc pyridine carboxylate complex composite catalyst and preparation method thereof 安徽普碳新材料科技有限公司 2025-02-21 CN claimed
CN-118878806-A Zinc pyridine carboxylate complex composite catalyst and preparation method thereof 安徽普碳新材料科技有限公司 2024-11-01 CN claimed
CN-117244593-A Solid acid catalyst and preparation method and application thereof 中国石油天然气股份有限公司 2023-12-19 CN claimed
CN-115594843-B Synthesis method of electronic mediator, biosensor and preparation method of biosensor 可孚医疗科技股份有限公司 2023-12-12 CN claimed
CN-115594843-A Synthesis method of electron mediator, biosensor and preparation method of biosensor 可孚医疗科技股份有限公司(CN) 2023-01-13 CN claimed
EP-3284847-B1 CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS HELMHOLTZ ZENTRUM GEESTHACHT (DE) 2019-01-02 EP claimed
JP-4279583-A None JP disclosed
US-12581252-B2 Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors RELAY THERAPEUTICS, INC. (US) 2026-03-17 US disclosed
US-20250362274-A1 SYSTEMS AND METHODS TO DETERMINE PARTITION COEFFICIENTS BETWEEN CRUDE OIL AND AN AQUEOUS PHASE SAUDI ARABIAN OIL CO (SA) 2025-11-27 US disclosed
US-20250180480-A1 DETERMINING PARTITION COEFFICIENTS OF TRACER ANALYTES SAUDI ARABIAN OIL COMPANY (SA) 2025-06-05 US disclosed
US-12253467-B2 Determining partition coefficients of tracer analytes SAUDI ARABIAN OIL COMPANY (SA) 2025-03-18 US disclosed
CN-118878806-B Zinc pyridine carboxylate complex composite catalyst and preparation method thereof 安徽普碳新材料科技有限公司 2025-02-21 CN disclosed
US-12219327-B2 Substituted isoindolines as PI3K-alpha inhibitors RELAY THERAPEUTICS, INC. (US) 2025-02-04 US disclosed
EP-0871065-A1 Method for processing a silver halide color photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1998-10-14 EP disclosed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 WO disclosed
JP-H04279583-A RHODIUM COMPLEX OF OPTICALLY ACTIVE 4-SUBSTITUTED-2,6-BIS(OXAZOLYL)PYRIDINE DERIVATIVE AND PRODUCTION OF ASYMMETRIC ALCOHOL USING THE SAME COMPLEX MITSUI TOATSU CHEM INC 1992-10-05 JP disclosed
US-5094759-A Method of water treatment using 2,6-substituted aminopyridines and polymer derived therefrom THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1992-03-10 US disclosed
US-5026802-A Polymers derived from 2,6-substituted-4-amino-pyridines THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1991-06-25 US disclosed
US-4940796-A 2,6-substituted-4-aminopyridines and their corresponding intermediates THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1990-07-10 US disclosed
US-4171313-A OF ALICYCLIC KETONES TO LACTONES, W-HYDROXY ACIDS AND ESTERS USING HYDROGEN PEROXIDE AS AN OXIDIZING AGENT ALLIED CHEMICAL CORPORATION (US) 1979-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12219327-B2 Substituted isoindolines as PI3K-alpha inhibitors PIK3CD, PIK3CB, PIK3R1 ALOX15 4083/4885TSHR 4529/4885HIF1A 2187/4885
US-12581252-B2 Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors RORB, ROR1, RORA ALOX15 3499/4885TSHR 146/4885HIF1A 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.